ABA therapy reduces CD28-negative CD4-positive T cell counts, and this reduction in CD28-negative T cell count is associated with the responsiveness of RA as assessed by DAS28 based on CRP level [56, 57]. Here, CD4 is linked to rheumatoid arthritis.